These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 8019750)
21. Modelling frequency- and voltage-dependent effects of a class I antiarrhythmic drug (nicainoprol) on Vmax of the cardiac action potential from guinea-pig papillary muscle. Weirich J; Antoni H Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):456-64. PubMed ID: 2586635 [TBL] [Abstract][Full Text] [Related]
22. Effects of bepridil on the electrophysiological properties of guinea-pig ventricular muscles. Anno T; Furuta T; Itho M; Kodama I; Toyama J; Yamada K Br J Pharmacol; 1984 Apr; 81(4):589-97. PubMed ID: 6609738 [TBL] [Abstract][Full Text] [Related]
23. Effects of AFD-21, a new class I antiarrhythmic agent, and AFD-19, its active metabolite, on the maximal rate of rise of action potentials in guinea pig papillary muscles: dependence on time, voltage, and action potential duration. Kojima M; Ban T J Cardiovasc Pharmacol; 1989 Mar; 13(3):483-93. PubMed ID: 2471896 [TBL] [Abstract][Full Text] [Related]
24. Electrophysiological properties of a new antiarrhythmic agent, bisaramil on guinea-pig, rabbit and canine cardiac preparations. Sunami A; Sawanobori T; Adaniya H; Hiraoka M Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):323-30. PubMed ID: 1961258 [TBL] [Abstract][Full Text] [Related]
25. Effects of tocainide and lidocaine on the transmembrane action potentials as related to external potassium and calcium concentrations in guinea-pig papillary muscles. Oshita S; Sada H; Kojima M; Ban T Naunyn Schmiedebergs Arch Pharmacol; 1980 Oct; 314(1):67-82. PubMed ID: 6777703 [TBL] [Abstract][Full Text] [Related]
26. Electrophysiological effects of AN-132, a new antiarrhythmic compound, in guinea pig papillary muscles. Imanishi S; Morita S; Arita M J Cardiovasc Pharmacol; 1990 Mar; 15(3):476-84. PubMed ID: 1691373 [TBL] [Abstract][Full Text] [Related]
27. Electrophysiological characterization of class III activity of a verapamil derivative in guinea-pig cardiac tissues. Kammer T; Berger F; Borchard U; Hafner D Arzneimittelforschung; 1993 Mar; 43(3):302-8. PubMed ID: 8489557 [TBL] [Abstract][Full Text] [Related]
29. Frequency- and voltage-dependent effects of recainam on the upstroke velocity of action potential in rabbit ventricular muscle. Kamiya K; Takikawa R; Singh BN J Cardiovasc Pharmacol; 1989 Apr; 13(4):630-7. PubMed ID: 2471002 [TBL] [Abstract][Full Text] [Related]
30. Effect of an antiarrhythmic agent, carocainide, on action potentials of ventricular papillary muscle of the guinea-pig heart in vitro. Muramoto J; Hotokebuchi N; Nishi K Arch Int Pharmacodyn Ther; 1991; 312():27-38. PubMed ID: 1772338 [TBL] [Abstract][Full Text] [Related]
31. Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia. MacKenzie I; Saville VL; Waterfall JF Br J Pharmacol; 1993 Oct; 110(2):531-8. PubMed ID: 8242227 [TBL] [Abstract][Full Text] [Related]
32. KCB-328: a novel class III antiarrhythmic agent with little reverse frequency dependence in isolated guinea pig myocardium. Lee K; Lee JY; Kim HY; Kwon LS; Shin HS; Tanabe S; Kozono T; Park SD; Chung YS J Cardiovasc Pharmacol; 1998 Apr; 31(4):609-17. PubMed ID: 9554812 [TBL] [Abstract][Full Text] [Related]
33. Effects of RS-2135, a new antiarrhythmic agent, on the kinetics of use-dependent decrease in maximum upstroke velocity in guinea pig ventricular myocardium. Yorikane R; Sada T; Koike H J Cardiovasc Pharmacol; 1993 Mar; 21(3):430-4. PubMed ID: 7681504 [TBL] [Abstract][Full Text] [Related]
34. Electrophysiological studies of indecainide hydrochloride, a new antiarrhythmic agent, in canine cardiac tissues. Steinberg MI; Wiest SA J Cardiovasc Pharmacol; 1984; 6(4):614-21. PubMed ID: 6206315 [TBL] [Abstract][Full Text] [Related]
35. Frequency- and voltage-dependent effects of aprindine on the upstroke velocity of action potential in guinea pig ventricular muscles. Toyama J; Kamiya K; Kodama I; Yamada K J Cardiovasc Pharmacol; 1987 Feb; 9(2):165-72. PubMed ID: 2435994 [TBL] [Abstract][Full Text] [Related]
36. Effects of altered extracellular potassium and pacing cycle length on the class III antiarrhythmic actions of dofetilide (UK-68,798) in guinea-pig papillary muscle. Yang T; Tande PM; Lathrop DA; Refsum H Cardiovasc Drugs Ther; 1992 Aug; 6(4):429-36. PubMed ID: 1520650 [TBL] [Abstract][Full Text] [Related]
37. Effects of 3,6-dimethylamino-dibenzopyriodonium edetate on action potentials in guinea pig papillary muscles. Ji GJ; Zhao DH; Liu DQ; Sheng BH Zhongguo Yao Li Xue Bao; 1993 Mar; 14(2):121-4. PubMed ID: 8352002 [TBL] [Abstract][Full Text] [Related]
38. [Frequency- and voltage-dependent effects of changrolin on maximal upstroke velocity of action potentials in guinea pig papillary muscles]. Pan H; Shen WQ; Yu ZM; Xu B Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):317-21. PubMed ID: 2104485 [TBL] [Abstract][Full Text] [Related]
40. Nicorandil shortens action potential duration and antagonises the reduction of Vmax by lidocaine but not by disopyramide in guinea-pig papillary muscles. Kojima M; Ban T Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):203-12. PubMed ID: 2966899 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]